PURPLE BIOTECH

PURPLE BIOTECH

Purple Biotech Ltd., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various pharmaceutical drugs in the United States. It operates through two segments, Oncology, and Pain and Hypertension. The company's marketed products include Consensi, a fixed-dose combination of celecoxib and amlodipine besylate for the simultaneous treatment of osteoarthritis pain and hypertension. Its oncology pipeline includes NT219, a small molecule that targets insulin rece... ptor substrate 1 and 2, and signal transducer and activator of transcription, which is in Phase 1/2 clinical trials for the treatment of recurrent and/or metastatic solid tumors and squamous cell carcinoma of the head and neck cancer; and CM-24, a monoclonal antibody blocking CEACAM1 that is being developed as a combination therapy with anti-PD-1 checkpoint inhibitors, which is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer and pancreatic cancer. The company was formerly known as Kitov Pharma Ltd and changed its name to Purple Biotech Ltd. in December 2020. Purple Biotech Ltd. was founded in 2010 and is headquartered in Rehovot, Israel.

Purple Biotech_logo

Industry:
Company

Address:
4 Oppenheimer Street, Rehovot, Israel Zipcode 7670104

Country:
Israel

Phone:
972 3 933 3121

Market Cap:
74.13M
Total Revenue:
1M
Total Assets:
83.8M
Total Cash:
11.25M


Key Executives
Name Title Pay Year Born
Mr. Isaac Israel CEO & Director 510,096$ 1978(42 years old)
Mr. Gil Efron CPA, M.A. Deputy CEO & CFO 380,315$ 1966(54 years old)
Dr. Bertrand C. Liang Chief Medical Officer 446,887$ 1963(57 years old)
Dr. Michael Schickler Head of Clinical Operations 219,137$ 1958(62 years old)
Mr. Ido Morpurgo VP Operations N/A 1973(47 years old)
Mr. Simcha Rock CPA, M.B.A., CPA, MBA Strategic Advisor & Director N/A 1950(70 years old)



Financial & Stock
Exchange NasdaqCM. Currency in USD. Market state POST
According to Purple Biotech's financial reports the company's revenue in 2020 were 1M an decrease(0%) over the years 2019 revenue that were of 1M. In 2020 the company's total earnings were -28M while total earnings in 2019 were -5.85M( +460%).
Company's stock symbol is PPBT. Lastest price : 4.0800. Total volume :272.72k Click reload if you want to check the lastest price on market!!!


Site Inspections: http://www.kitovpharma.com

  • Host name: web1.mosesnet.net
  • IP address: 185.149.254.69
  • Location: Jerusalem Israel
  • Latitude: 31.7808
  • Longitude: 35.2287
  • Timezone: Asia/Jerusalem

Loading ...
Loading ...


More informations about "Purple Biotech" on Search Engine

Purple Biotech first-in-class therapies to overcome tumor

Purple-biotech.com Purple BioTech - are committed to providing cancer patients with first-in-class, effective, and durable therapies by overcoming tumor immune evasion and drug resistance.

Purple Biotech first-in-class therapies to overcome tumor

Purple-biotech.com Purple Biotech Ltd. is a clinical-stage company focusing on advancing first-in …

Purple Biotech first-in-class therapies to overcome tumor

Purple-biotech.com Purple Biotech Ltd. (NASDAQ/TASE: PPBT) is a clinical-stage company focused on …

Purple Biotech first-in-class therapies to overcome tumor

Purple-biotech.com About CONSENSI® Consensi ®️ is a fixed-dose combination of celecoxib, a non …

Purple Biotech first-in-class therapies to overcome tumor

Purple-biotech.com Please contact us for more information about, CM24, NT219 resistance and reversing …

Purple Biotech Ltd. (PPBT) Stock Price, News, Quote

Finance.yahoo.com About Purple BiotechPurple Biotech Ltd. (the “Company”; NASDAQ/TASE: PPBT) is a clinical-stage company focusing on advancing first-in-class therapies to overcome tumor immune evasion and drug...

PPBT Purple Biotech ADR — Stock Price and Discussion

Stocktwits.com Apr 09, 2021 · Purple Biotech ADR NASDAQ Updated Apr 9, 2021 7:59 PM. PPBT 4.31 0.04 (0.94%). 8,182

Purple Biotech Presents Additional Mechanism of Action

Finance.yahoo.com About Purple Biotech Purple Biotech Ltd. (f/k/a Kitov Pharma Ltd.) (the “Company”; NASDAQ/TASE: KTOV) is a clinical-stage company developing first-in-class therapies by overcoming tumor immune ...

PPBT Stock Forecast, Price & News (Purple Biotech)

Marketbeat.com Purple Biotech has a market capitalization of $68.40 million and generates $1 million in revenue each year. The company earns $-5,850,000.00 in net income (profit) each year or ($3.00) on an earnings per share basis. How many employees does Purple Biotech have? Purple Biotech employs 13 workers across the globe.

PPBT - Purple Biotech Ltd Stock quote - CNNMoney.com

Money.cnn.com Find real-time PPBT - Purple Biotech Ltd stock quotes, company profile, news and forecasts from CNN Business.

Kitov Announces Name Change to Purple Biotech Ltd.

Finance.yahoo.com Dec 10, 2020 · In connection with the name change, the Company expects to make additional ordinary course filings with the U.S. Securities and Exchange Commission.About Purple Biotech Purple Biotech …

Purple Biotech Ltd. American Depositary Shares (PPBT)

Nasdaq.com Purple Biotech Ltd. American Depositary Shares (PPBT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Purple Biotech Ltd - Company Profile and News - Bloomberg

Bloomberg.com Purple Biotech Ltd operates as a pharmaceutical company. The Company discovers and develops medicines, drugs, and other pharmaceutical products for the treatment of osteoarthritis pain and ...

Purple Biotech Presents Additional Mechanism of Action

Markets.businessinsider.com 9 hours ago · Purple Biotech Ltd. (f/k/a Kitov Pharma Ltd.) (the “Company”; NASDAQ/TASE: KTOV) is a clinical-stage company developing first-in-class therapies by overcoming tumor immune evasion and …

Purple Biotech Ltd. (PPBT) Stock Forum & Discussion

Finance.yahoo.com Purple Biotech Shares Move Higher; Kitov Pharmaceuticals (Former Company Name) To Be Issued U.S. Patent 'CELECOXIB AND AMLODIPINE FORMULATION AND METHOD OF MAKING THE SAME' 2/12/21, 12:19 PM

PURPLE BIOTECH Share Price - PPBT Share Price

Stockopedia.com Purple Biotech Ltd, formerly Kitov Pharma Ltd, is an Israel-based clinical-stage company that develops drugs that overcome tumor-immune evasion and drug resistancetreat pain. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance ...

Kitov Announces Name Change to Purple Biotech Ltd. Nasdaq:PPBT

Globenewswire.com Dec 10, 2020 · Purple Biotech Ltd. (f/k/a Kitov Pharma Ltd.) (the “Company”; NASDAQ/TASE: KTOV) is a clinical-stage company focusing on advancing first-in-class therapies to overcome tumor immune evasion and drug...

Purple Biotech Presents Additional Mechanism of Action

Marketscreener.com 10 hours ago · About Purple Biotech. Purple Biotech Ltd. (f/k/a Kitov Pharma Ltd.) (the “Company”; NASDAQ/TASE: KTOV) is a clinical-stage company developing first-in-class therapies by overcoming tumor immune evasion and drug resistance. The Company’s oncology pipeline includes NT219 and CM24. NT219 is a dual inhibitor, novel small molecule that ...

Is Purple Biotech Ltd. (NASDAQ:PPBT) Expensive At $4.21

Marketingsentinel.com Mar 27, 2021 · Purple Biotech Ltd. (NASDAQ:PPBT) trade information. In the face of being in the red during last session for losing -1.86%, in the last five days PPBT remained trading in the green while hitting it’s week-highest on Monday, Mar 22 when the stock touched $4.75-1 price level, adding 11.37% to its value on the day.

Purple Biotech (TASE:PPBT) - Share price, News & Analysis

Simplywall.st Purple Biotech Ltd., a clinical-stage pharmaceutical company, focuses on the development and commercialization of various pharmaceutical drugs in the United States. More Details. Risk Analysis. Earnings have declined by 24.1% per year over past 5 years. Highly volatile share price over the past 3 …

PPBT Stock Price | Purple Biotech Ltd. ADR Stock Quote (U)

Marketwatch.com Apr 08, 2021 · Purple Biotech Ltd. ADR. Purple Biotech Ltd. is a development stage pharmaceutical company, which engages in drug development. It operates through …

PPBT: Purple Biotech Ltd - Stock Price, Quote and News - CNBC

Cnbc.com Purple Biotech Ltd, formerly Kitov Pharma Ltd, is an Israel-based clinical-stage company that develops drugs that overcome tumor-immune evasion and drug resistancetreat pain.

PPBT Stock Price, Purple Biotech Stock Quotes and News

Benzinga.com Jan 01, 2019 · Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, to …

PPBT | Purple Biotech Ltd. ADR Stock Price & News - WSJ

Wsj.com View the latest Purple Biotech Ltd. ADR (PPBT) stock price, news, historical charts, analyst ratings and financial information from WSJ.

PPBT:NASDAQ CM Stock Quote - Purple Biotech Ltd

Bloomberg.com Purple Biotech Ltd operates as a pharmaceutical company. The Company discovers and develops medicines, drugs, and other pharmaceutical products for the treatment of osteoarthritis pain and ...

Purple Biotech Ltd - ADR PPBT - Quotes, Financials, News

Money.usnews.com Purple Biotech Ltd. is a development stage pharmaceutical company, which engages in drug development. It operates through two segments: Oncology, …

Purple Biotech Rings the Nasdaq Stock Market Opening Bell

Jlm-biocity.org Jan 17, 2021 · Purple Biotech (NASDAQ/TASE: PPBT) is a clinical-stage company focusing on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance in order to create successful long-lasting treatments for people with cancer. The Company’s oncology pipeline includes NT219 and CM24.

Purple Biotech Ltd Earnings & Revenue 2011-2021: (NASDAQ)

Wallstreetzen.com As of Q2 2021, Purple Biotech Ltd's revenue has grown 0% year over year. This is 351.76 percentage points lower than the US Biotechnology industry revenue growth rate of 351.76%. Purple Biotech Ltd's revenue in the past year totalled $1.00 million. ©

Purple Biotech Announces Initiation of Phase 1b/2 Clinical

Markets.businessinsider.com Mar 19, 2021 · Purple Biotech Ltd. (f/k/a Kitov Pharma Ltd.) (the “Company”; NASDAQ/TASE: KTOV) is a clinical-stage company developing first-in-class therapies …

Purple Biotech | LinkedIn

Linkedin.com Purple Biotech 2mo Happy to present new data supporting the mechanism of action of NT219, a dual inhibitor, novel small molecule targeting IRS1/2 and STAT3 at the Epigenetics and Metabolism AACR...

Purple Biotech ADR (PPBT : NASDAQ) Stock Price & News

Google.com Get the latest Purple Biotech ADR (PPBT) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

PPBT | Purple Biotech Ltd. ADR Company Profile

Wsj.com Purple Biotech Ltd. is a development stage pharmaceutical company, which engages in drug development. It operates through two segments: Oncology, and Pain & Hypertension.

Purple Biotech to Ring the Nasdaq Stock Market Opening

Globenewswire.com Jan 04, 2021 · Purple Biotech Ltd. (the “Company”; NASDAQ/TASE: PPBT) is a clinical-stage company focusing on advancing first-in-class therapies to overcome tumor immune evasion and …

Purple Biotech to Present at the B. Riley Oncology

Globenewswire.com Jan 18, 2021 · Purple Biotech Ltd. (the “Company”; NASDAQ/TASE: PPBT) is a clinical-stage company focusing on advancing first-in-class therapies to overcome tumor immune evasion and …

PPBT Stock - Purple Biotech Ltd. SEC Filings

Sec.report Purple Biotech Ltd. is regulated by the U.S. Security and Exchange Commission and incorporated in the state of Israel. Purple Biotech Ltd is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st.

Purple Biotech Ltd Stock Ownership - Who Owns Purple

Wallstreetzen.com Purple Biotech Ltd (NASDAQ: PPBT) is owned by 57.04% institutional shareholders, 0.00% Purple Biotech Ltd insiders, and 42.96% retail investors. Morgan Stanley is the largest individual Purple Biotech Ltd shareholder, owning 494,715.00 shares representing 25.29% of the company.

Purple Biotech to Present Additional Mechanism of Action

Finance.yahoo.com Mar 11, 2021 · About Purple Biotech Purple Biotech Ltd. (the “Company”; NASDAQ/TASE: PPBT) is a clinical-stage company developing first-in-class, effective …

Purple Biotech Ltd Stock Price Today (NASDAQ: PPBT) Quote

Wallstreetzen.com Apr 08, 2021 · Purple Biotech Ltd. stock was originally listed at a price of $31.90 in Nov 20, 2015. If you had invested in Purple Biotech Ltd stock at $31.90, your return over the last 5 years would have been -86.61%, for an annualized return of -33.12%.

PPBT News Today (Purple Biotech) | MarketBeat

Marketbeat.com Purple Biotech Ltd. (PPBT) ca.finance.yahoo.com - January 6 at 12:57 AM: Purple Biotech Ltd. Rings the Opening Bell nasdaq.com - January 5 at 9:36 AM: Purple Biotech to Ring the Nasdaq Stock Market Opening Bell finance.yahoo.com - January 4 at 1:35 PM: Purple Biotech Ltd. ADR wsj.com - …

PPBT Stock: 9 Things for Investors to Know About Purple

Investorplace.com Feb 10, 2021 · Purple Biotech clinical-stage company developing therapies to treat tumor immune evasion and drug resistance. The company’s oncology pipeline includes NT219 and CM24 treatments.

Purple Biotech Appoints Biopharmaceutical Industry Veteran

Globenewswire.com Mar 03, 2021 · Purple Biotech Ltd. (the “Company”; NASDAQ/TASE: PPBT) is a clinical-stage company focusing on advancing first-in-class therapies to overcome tumor immune evasion and …

Purple Biotech to Ring the Nasdaq Stock Market Opening

Bloomberg.com Jan 04, 2021 · About Purple Biotech Purple Biotech Ltd. (the “Company”; NASDAQ/TASE: PPBT) is a clinical-stage company focusing on advancing first-in-class therapies to …

Kitov Announces Name Change to Purple Biotech Ltd. | Nasdaq

Nasdaq.com Dec 10, 2020 · --Purple Biotech Ltd., a clinical-stage company advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, today announced that it …

Purple Biotech to Ring the Nasdaq Stock Market Opening

Nasdaq.com Jan 04, 2021 · About Purple Biotech Purple Biotech Ltd. (the “Company”; NASDAQ/TASE: PPBT) is a clinical-stage company focusing on advancing first-in-class therapies to …

Purple Biotech - Home | Facebook

Facebook.com Purple Biotech. 51 likes. A reliable supplier, marketer & distributor of medical consumables. Global supplier of a wide range of diagnostic test kits.

Purple Biotech : Launches Phase 1b/2 Study of CM24 With

Marketscreener.com Purple Biotech Ltd. on Friday said it is launching a Phase 1b/2 clinical trial in collaboration with Bristol Myers Squibb Co. evaluating Purple's CM24 monoclonal antibody for the treatment of multiple advanced cancers. The Rehovot, Israel, clinical-stage company said the study will evaluate CM24 in combination with Bristol's blockbuster cancer ...